Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.

Sharma M, Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S, van de Rijn M, Jensen KC, West RB.

Breast Cancer Res Treat. 2010 Sep;123(2):397-404. doi: 10.1007/s10549-009-0654-0.

2.

A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth.

Qian B, Deng Y, Im JH, Muschel RJ, Zou Y, Li J, Lang RA, Pollard JW.

PLoS One. 2009 Aug 10;4(8):e6562. doi: 10.1371/journal.pone.0006562.

3.

The macrophage colony-stimulating factor 1 response signature in breast carcinoma.

Beck AH, Espinosa I, Edris B, Li R, Montgomery K, Zhu S, Varma S, Marinelli RJ, van de Rijn M, West RB.

Clin Cancer Res. 2009 Feb 1;15(3):778-87. doi: 10.1158/1078-0432.CCR-08-1283.

4.

Estimation of tumor heterogeneity using CGH array data.

Wang K, Li J, Li S, Bolund L, Wiuf C.

BMC Bioinformatics. 2009 Jan 9;10:12. doi: 10.1186/1471-2105-10-12.

5.

Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis.

Li J, Gromov P, Gromova I, Moreira JM, Timmermans-Wielenga V, Rank F, Wang K, Li S, Li H, Wiuf C, Yang H, Zhang X, Bolund L, Celis JE.

Proteomics. 2008 Dec;8(23-24):5038-52. doi: 10.1002/pmic.200800303.

PMID:
19003862
6.

The fibromatosis signature defines a robust stromal response in breast carcinoma.

Beck AH, Espinosa I, Gilks CB, van de Rijn M, West RB.

Lab Invest. 2008 Jun;88(6):591-601. doi: 10.1038/labinvest.2008.31.

7.

High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R.

Clin Cancer Res. 2007 Mar 1;13(5):1472-9.

8.

No common denominator for breast cancer lymph node metastasis.

Weigelt B, Wessels LF, Bosma AJ, Glas AM, Nuyten DS, He YD, Dai H, Peterse JL, van't Veer LJ.

Br J Cancer. 2005 Oct 17;93(8):924-32.

9.

Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density.

Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S.

Oncol Rep. 2005 Aug;14(2):425-31.

PMID:
16012726
10.

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

Farinha P, Masoudi H, Skinnider BF, Shumansky K, Spinelli JJ, Gill K, Klasa R, Voss N, Connors JM, Gascoyne RD.

Blood. 2005 Sep 15;106(6):2169-74.

11.

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.

Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA.

Cell. 2005 May 6;121(3):335-48.

12.

Determination of stromal signatures in breast carcinoma.

West RB, Nuyten DS, Subramanian S, Nielsen TO, Corless CL, Rubin BP, Montgomery K, Zhu S, Patel R, Hernandez-Boussard T, Goldblum JR, Brown PO, van de Vijver M, van de Rijn M.

PLoS Biol. 2005 Jun;3(6):e187.

13.

Friends or foes - bipolar effects of the tumour stroma in cancer.

Mueller MM, Fusenig NE.

Nat Rev Cancer. 2004 Nov;4(11):839-49. Review.

PMID:
15516957
14.

Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer.

Ohno S, Ohno Y, Suzuki N, Kamei T, Koike K, Inagawa H, Kohchi C, Soma G, Inoue M.

Anticancer Res. 2004 Sep-Oct;24(5C):3335-42.

15.

Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.

Koide N, Nishio A, Sato T, Sugiyama A, Miyagawa S.

Am J Gastroenterol. 2004 Sep;99(9):1667-74.

PMID:
15330899
16.

Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis.

Hao X, Sun B, Hu L, Lähdesmäki H, Dunmire V, Feng Y, Zhang SW, Wang H, Wu C, Wang H, Fuller GN, Symmans WF, Shmulevich I, Zhang W.

Cancer. 2004 Mar 15;100(6):1110-22.

17.

The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients.

Ohno S, Inagawa H, Dhar DK, Fujii T, Ueda S, Tachibana M, Suzuki N, Inoue M, Soma G, Nagasue N.

Anticancer Res. 2003 Nov-Dec;23(6D):5015-22.

PMID:
14981961
18.

Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis.

Kluger HM, Dolled-Filhart M, Rodov S, Kacinski BM, Camp RL, Rimm DL.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):173-7.

19.

Gene expression profiles of primary breast tumors maintained in distant metastases.

Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15901-5.

20.

Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma.

Hamada I, Kato M, Yamasaki T, Iwabuchi K, Watanabe T, Yamada T, Itoyama S, Ito H, Okada K.

Anticancer Res. 2002 Nov-Dec;22(6C):4281-4.

PMID:
12553070
Items per page

Supplemental Content

Support Center